Note: Xoma's revenues are gauged from an analysis of company filings.
Trademark applications show the products and services that Xoma is developing and marketing.
Xoma doesn't have any recent trademark applications, indicating Xoma is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
AEROPREX pharmaceutical products, namely, pharmaceutical preparations for use in pulmonary applications
MYCOPREX antifungal preparations for human use only
I-PREX pharmaceutical products, namely pharmaceutical products for use in ophthalmologic applications
Determine whether Xoma grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Xoma is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
A competitive analysis shows these companies are in the same general field as Xoma, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are in the same general field as Xoma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.